A photon spectrometric dose-rate constant determination for the Advantage Pd-103 brachytherapy source

Area of Science:

• Medical Physics
• Radiotherapy Dosimetry

Background:

• The Advantage Pd-103 source is a new brachytherapy option.
• Existing dosimetric characterizations lack an established AAPM consensus value.

Purpose of the Study:

• To determine the dose-rate constant (λ) for the Advantage Pd-103 source.
• To utilize a photon spectrometry technique (PST) independent of TLD and Monte Carlo methods.

Main Methods:

• Measured photon energy spectra from three Advantage Pd-103 sources using a germanium spectrometer.
• Calculated dose-rate constants from the measured spectra (PST λ).
• Compared PST λ with published TLD (TLD λ) and Monte Carlo (MC λ) values.

Main Results:

• The average PST λ was 0.676 ± 0.026 cGy·h⁻¹·U⁻¹ with minimal intersource variation.
• PST λ agreed within 2% with MC λ and was 3.4% lower than TLD λ.
• A consensus λ of 0.688 ± 0.026 cGy·h⁻¹·U⁻¹ was estimated, consistent with other 103Pd sources.

Conclusions:

• Photon spectrometry provides an independent determination of the Advantage Pd-103 source's dose-rate constant.
• This study contributes crucial data for establishing an accurate AAPM consensus λ value.